Skip to main content
editor.ajphr@gmail.com
9409046853
e-ISSN: 2321-3647
American Journal of Pharmacy and Health Research

American Journal of Pharmacy and Health Research

Published

Comparison and Evaluation of Marketed Tablet of Spironolactone

Published in March 2024 Issue 03 (Vol. 12, Issue 3, 2024)

Comparison and Evaluation of Marketed Tablet of Spironolactone - Issue cover

Abstract

ABSTRACTThe primary goal is to evaluate and compare the quality standards of branded and generic forms of the antihypertensive medication (Spironolactone). The drugs are evaluated and results showed that branded and generic meet the pharmacopoeial specifications. According to pharmacopeia, every tablet passed the test for weight fluctuation, hardness, friability, disintegration and dissolution. Thus, we can say that antihypertensive medications are equal. Keywords: Spironolactone; Physicochemical test; In-vitro studies.

Citations & discovery

Explore citations to this article and find it in scholarly databases.

Crossref
…
Citations
View record
Europe PMC
…
DOI matches
View results
Google Scholar

Checking citation sources…

Citation counts reflect each source's coverage. Europe PMC shows DOI search matches, including mentions in references. Article lists may be incomplete. Google Scholar opens a separate search.

Authors (2)

Download Article

PDF

Best for printing and citation

File size: 0.0 MB
Format: PDF

Summarise this paper with AI:

Article Information

AJPHR1203001

AJPHR-01-000869

1-8

2024-03-01

JATS XML

Article Impact

Views:4,938
Downloads:817
scite_
PlumX Metrics Badge

How to Cite

Samyuktha.S¹, & K, B. (2024). Comparison and Evaluation of Marketed Tablet of Spironolactone. American Journal of Pharmacy and Health Research, 12(3), 1-8. https://doi.org/10.5281/zenodo.13833114

Article Actions

Whatsapp